MedTrace Logo

Tear Lipid Layer Thickness Assessments With Perfluorohexyloctane Eye Drops

NCT05288582 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2023-02-08

No results posted yet for this study

Summary

The purpose of this study is to explore the tear lipid layer quantitatively and qualitatively before and after use of a perflurohexyloctane eye drop (NovaTears)

Conditions

  • Dry Eye

Interventions

DEVICE

NovaTears

Over-the-counter eye drop

Sponsors & Collaborators

  • Ohio State University

    lead OTHER

Principal Investigators

  • Jennifer Fogt, OD MS · OSU College of Optometry

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-27
Primary Completion
2022-07-31
Completion
2022-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05288582 on ClinicalTrials.gov